Difference between revisions of "Part:BBa K929004"
(12 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K929004 short</partinfo> | <partinfo>BBa_K929004 short</partinfo> | ||
+ | <p style="background-color: rgb(238, 221, 130); font-weight: bold;">General information</p> | ||
+ | |||
{| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right" | {| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right" | ||
− | ! colspan="2" style="background: | + | ! colspan="2" style="background:rgb(240, 20, 70);"| modified AID+eGFP |
|- | |- | ||
! colspan="2"|[[Image:UP12_Part_mod_AIDandeGFP.png|300px]] | ! colspan="2"|[[Image:UP12_Part_mod_AIDandeGFP.png|300px]] | ||
Line 13: | Line 15: | ||
|- | |- | ||
|'''Requirement''' | |'''Requirement''' | ||
− | |pSB1C3 | + | |pSB1C3 |
|- | |- | ||
|'''Source''' | |'''Source''' | ||
− | |existing parts: BBa_K404316 and | + | |existing parts: [https://parts.igem.org/Part:BBa_K404316 BBa_K404316] and [https://parts.igem.org/Part:BBa_K929001 BBa_K929001] |
|- | |- | ||
|'''Submitted by''' | |'''Submitted by''' | ||
|[http://2012.igem.org/Team:Potsdam_Bioware Potsdam_Bioware2012] | |[http://2012.igem.org/Team:Potsdam_Bioware Potsdam_Bioware2012] | ||
|} | |} | ||
− | + | [[Image:UP12_Plasmid_modAIDandeGFP.png|left|thumb|400px]]<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | |
− | [[Image:UP12_Plasmid_modAIDandeGFP.png|left|thumb|400px]]<br><br><br><br><br><br><br><br><br><br><br><br><br> | + | |
− | This is a composite part from the existing parts: modified_AID ([https://parts.igem.org/Part:BBa_K929001 BBa_K929001]) and eGFP ([https://parts.igem.org/Part:BBa_K404316 BBa_K404316]). Modified_AID ( | + | This is a composite part from the existing parts: modified_AID ([https://parts.igem.org/Part:BBa_K929001 BBa_K929001]) and eGFP ([https://parts.igem.org/Part:BBa_K404316 BBa_K404316]). Modified_AID ([https://parts.igem.org/Part:BBa_K929001 BBa_K929001]) is in RFC 10 cloning standard and has an aditional AgeI restriciton site. Therefore it can be fused with RFC 25 parts (C-terminal of modified AID), see [https://parts.igem.org/Part:BBa_K929004:Design Part_Design]. This part was '''not''' used to express the fusion protein. It is an usefull intermediate that can be combined with differnt promoters and terminators. We combined this part with CMV-promoter and polyA-hGH (poly adenylation signal sequence)--> see [https://parts.igem.org/Part:BBa_K929002 BBa_929002]. |
'''AID''': | '''AID''': | ||
Line 49: | Line 50: | ||
This part has an aditional AgeI restriction site because its precursor "modified AID+eGFP"([https://parts.igem.org/Part:BBa_K929004 BBa_K929004]) was build of an RFC 25 part that has an AgeI restriction site in front of its stop codon. Therefore incompatibility with RFC 25 is displayed. Actually fusion with RFC 25 parts is possible (C-terminal of CMV-modified AID-eGFP) but hGH polyadenylatiosequence must be added again. CMV promoter and hGH-polyadenylation sequence were added via serial cloning (see [https://parts.igem.org/Part:BBa_K929003:Design PartDesign]).<br> | This part has an aditional AgeI restriction site because its precursor "modified AID+eGFP"([https://parts.igem.org/Part:BBa_K929004 BBa_K929004]) was build of an RFC 25 part that has an AgeI restriction site in front of its stop codon. Therefore incompatibility with RFC 25 is displayed. Actually fusion with RFC 25 parts is possible (C-terminal of CMV-modified AID-eGFP) but hGH polyadenylatiosequence must be added again. CMV promoter and hGH-polyadenylation sequence were added via serial cloning (see [https://parts.igem.org/Part:BBa_K929003:Design PartDesign]).<br> | ||
− | + | <p style="background-color: rgb(238, 221, 130); font-weight: bold;">Characterization</p> | |
− | + | To characterize the modified AID+eGFP fusion protein, we added a (strong) CMV promoter and a hGH polyadenylation sequence. See the characterization of the resulting part "modified AID with CMV, hGH-polyA and eGFP" ([https://parts.igem.org/Part:BBa_K929003 BBa_K929003]). <br><br> | |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== |
Latest revision as of 22:43, 29 September 2012
modified AID+eGFP
General information
modified AID+eGFP | |
---|---|
BioBrick Nr. | BBa_K929004 |
RFC standard | RFC 10 and aditional AgeI site |
Requirement | pSB1C3 |
Source | existing parts: BBa_K404316 and BBa_K929001 |
Submitted by | [http://2012.igem.org/Team:Potsdam_Bioware Potsdam_Bioware2012] |
This is a composite part from the existing parts: modified_AID (BBa_K929001) and eGFP (BBa_K404316). Modified_AID (BBa_K929001) is in RFC 10 cloning standard and has an aditional AgeI restriciton site. Therefore it can be fused with RFC 25 parts (C-terminal of modified AID), see Part_Design. This part was not used to express the fusion protein. It is an usefull intermediate that can be combined with differnt promoters and terminators. We combined this part with CMV-promoter and polyA-hGH (poly adenylation signal sequence)--> see BBa_929002.
AID:
AID is known to be responsible for somatic hypermutation and the class-switch recombination of immunoglobulin in B cells. This enzyme of 28 kDa originally occurs in B cells but does also show activity after transfection into CHO cells. AID induces the deamination of cytidine to uridine at actively transcribed single strand DNA. The replacement of cytidine by uridine leads to a mismatch during DNA replication and integrates a single base substitution predominantly in the immunoglobulin genes.
The AID motif is naturally terminated with the Nuclear Export Sequence (NES) that causes the protein to translocate from the nucleus to the cytoplasm. Additionally, upstream, dysfunctional Nuclear Localization Sequence (NLS) is located. Due to the fact that AID mutates the actively transcribed single stranded DNA, it is supposed that the direction of the enzyme to the inside of the nucleus would improve the mutation rate.
Functional NLS sequence:
This part of the BioBrick directs the expressed protein into the nucleus, where it can mutate stronger.
Kozak sequence
Kozak consensus sequence is added upstream of the AID mutant to express the protein stronger.
eGFP:
In order to test where and if the AID modified sequence is functional we added to it a eGFP protein. It is used as a marker gene for detection of transfected cells, e.g. tumor cells.
Aditional AgeI restriciton site
This part has an aditional AgeI restriction site because its precursor "modified AID+eGFP"(BBa_K929004) was build of an RFC 25 part that has an AgeI restriction site in front of its stop codon. Therefore incompatibility with RFC 25 is displayed. Actually fusion with RFC 25 parts is possible (C-terminal of CMV-modified AID-eGFP) but hGH polyadenylatiosequence must be added again. CMV promoter and hGH-polyadenylation sequence were added via serial cloning (see PartDesign).
Characterization
To characterize the modified AID+eGFP fusion protein, we added a (strong) CMV promoter and a hGH polyadenylation sequence. See the characterization of the resulting part "modified AID with CMV, hGH-polyA and eGFP" (BBa_K929003).
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 1296
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 108
Illegal BsaI.rc site found at 1225
Illegal SapI site found at 209